Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Su, Jun  [Clear All Filters]
2023
Cao Y, Tang L, Su J, Wang H, Liang P, Rong K, Gong T. Generation of a TRPV1 knockout human pluripotent stem cell line (WAe009-A-U) using CRISPR/Cas9. Stem Cell Res. 2023;72:103202.
Wang P, Su J, Wang J, Xie Y, Chen W, Zhong J, Wang Y. NRF1 promotes primordial germ cell development, proliferation and survival. Cell Prolif. 2023:e13533.
Zhou J, Cui B, Wang X, Wang H, Zheng J, Guo F, Sun Y, Fan H, Shen J, Su J, et al. Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes. Stem Cell Res Ther. 2023;14(1):92.
Cai D, Wang X, Sun Y, Fan H, Zhou J, Yang Z, Qiu H, Wang J, Su J, Gong T, et al. Patient-specific iPSC-derived cardiomyocytes reveal aberrant activation of Wnt/β-catenin signaling in SCN5A-related Brugada syndrome. Stem Cell Res Ther. 2023;14(1):241.
Sun Y, Su J, Wang X, Wang J, Guo F, Qiu H, Fan H, Cai D, Wang H, Lin M, et al. Patient-specific iPSC-derived cardiomyocytes reveal variable phenotypic severity of Brugada syndrome. EBioMedicine. 2023;95:104741.
2021
Röth A, Fryzek J, Jiang X, Reichert H, Patel P, Su J, Arias JMorales, Broome CM. Complement-mediated hemolysis persists year round in patients with cold agglutinin disease. Transfusion. 2021.
Zhou D, Tan Y, Liu X, Tang L, Wang H, Shen J, Wang W, Zhuang L, Tao J, Su J, et al. Patient-specific iPSC-derived endothelial cells reveal aberrant p38 MAPK signaling in atypical hemolytic uremic syndrome. Stem Cell Reports. 2021.
2020
Zhou D, Sun Y, Shen J, Su J, Gong T, Jiang C, Liang P. Generation of an induced pluripotent stem cell line from the dermal fibroblasts of a patient with arrhythmogenic right ventricular cardiomyopathy carrying a PKP2/c.2489 + 1G > A mutation. Stem Cell Res. 2020;48:101965.
Su J, Wang J, Wang L, Li T, Wang H, Shen J, Wang H, Zhang J, Lin W, Huang J, et al. Generation of five induced pluripotent stem cell lines with DMD/c.497G > T mutation from renal epithelial cells of a Duchenne muscular dystrophy patient and a recessive carrier parent. Stem Cell Res. 2020;49:102021.
Wang J, Su J, Gong T, Li T, Shen J, Wang H, Xie H, Zhou L, Zheng S, Liang P. Generation of ZJUi003-A, an induced pluripotent stem cell line from a Wilson's disease patient carrying a c.180_181del mutation in ATP7B gene. Stem Cell Res. 2020;46:101873.
Tang L, Wang H, Dai B, Wang X, Zhou D, Shen J, Guo F, Wang J, Zhou J, Wang H, et al. Human induced pluripotent stem cell-derived cardiomyocytes reveal abnormal TGFβ signaling in type 2 diabetes mellitus. J Mol Cell Cardiol. 2020.
2019
Yang J, Su J, Xi S-S, Ke X-F, Zhu Y, Lin H-P, Zeng X-K, Liu B-W, Zhu M-L, Dai W-Y, et al. Human umbilical cord mesenchymal stem cells pretreated with Angiotensin-II attenuate pancreas injury of rats with severe acute pancreatitis. Biomed Pharmacother. 2019;117:109052.
2018
Tang L, Yao F, Wang H, Wang X, Shen J, Dai B, Wu H, Zhou D, Guo F, Wang J, et al. Inhibition of TRPC1 prevents cardiac hypertrophy via NF-κB signaling pathway in human pluripotent stem cell-derived cardiomyocytes. J Mol Cell Cardiol. 2018.